Department of Clinical Laboratory, 117742First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Department of Blood Transfusion, 477292Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Cancer Control. 2022 Jan-Dec;29:10732748221091333. doi: 10.1177/10732748221091333.
Ample evidence has revealed that the lymphocyte-to-monocyte ratio (LMR), albumin-to-globulin ratio (AGR), and mean platelet volume (MPV) are cancer-related inflammatory markers. The present study aimed to combine these indicators to better assess the progression of colon cancer.
This retrospective study enrolled 251 patients with colon cancer, 171 patients with benign colon diseases, and 187 healthy control subjects. The receiver operating characteristic curve and area under the curve (AUC) were used to determine the diagnostic values of the selected inflammatory index.
The levels of LMR, AGR, and MPV were decreased in the colon cancer group compared with the healthy control and benign colon disease groups. The LMR, AGR, and MPV were all correlated with tumor size. Moreover, LMR and AGR was associated with lymph node metastasis and clinical stage, AGR was related to distant metastasis. Both the LMR ( = .030) and AGR ( = .005) were negatively correlated with the concentration of carcinoembryonic antigen (CEA). The AUC value of MPV combined with CEA had a good diagnostic ability for distinguishing colon cancer cases (AUC = .950) and patients with benign colon diseases (AUC = .886) from controls. Meanwhile, the combination of LMR or AGR with CEA could enhance larger AUC (.746 for LMR + CEA, .737 for AGR + CEA) than CEA, LMR, or AGR alone in detecting colon cancer from benign colon diseases.
CEA combined with the LMR, AGR, or MPV may be used as better blood-based biomarkers in the progression of colon cancer patients.
大量证据表明,淋巴细胞与单核细胞比值(LMR)、白蛋白与球蛋白比值(AGR)和血小板平均体积(MPV)均为与癌症相关的炎症标志物。本研究旨在结合这些指标以更好地评估结肠癌的进展情况。
本回顾性研究纳入了 251 例结肠癌患者、171 例良性结肠疾病患者和 187 例健康对照者。采用受试者工作特征曲线和曲线下面积(AUC)来确定所选炎症指标的诊断价值。
与健康对照组和良性结肠疾病组相比,结肠癌组的 LMR、AGR 和 MPV 水平降低。LMR、AGR 和 MPV 均与肿瘤大小相关。此外,LMR 和 AGR 与淋巴结转移和临床分期相关,AGR 与远处转移相关。LMR( =.030)和 AGR( =.005)均与癌胚抗原(CEA)浓度呈负相关。MPV 联合 CEA 的 AUC 值对于区分结肠癌病例(AUC =.950)和良性结肠疾病患者(AUC =.886)与对照组具有良好的诊断能力。同时,LMR 或 AGR 与 CEA 的联合应用可增强 CEA、LMR 或 AGR 单独用于检测结肠癌与良性结肠疾病时的 AUC(LMR+CEA 的 AUC 值为.746,AGR+CEA 的 AUC 值为.737)。
CEA 联合 LMR、AGR 或 MPV 可作为评估结肠癌患者病情进展的更好的基于血液的生物标志物。